VEGF-C Antibodies

Santa Cruz Biotechnology delivers a wide array of VEGF-C monoclonal antibodies for research in vascular biology and related fields. VEGF-C monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Vascular Endothelial Growth Factor C (VEGF-C) plays a crucial role in lymphangiogenesis and the formation of blood vessels, making it an important target for studies related to cancer, inflammation, and tissue repair. By promoting the growth of lymphatic vessels, VEGF-C is implicated in the spread of tumors and the regulation of immune responses. Understanding VEGF-C function is essential for developing therapeutic strategies aimed at controlling angiogenesis and lymphangiogenesis. VEGF-C research has revealed significant insights into tumor metastasis and inflammatory conditions. Ongoing studies continue to uncover new aspects of VEGF-C signaling pathways and their impact on disease progression. Current research focuses on targeting VEGF-C mechanisms for potential therapeutic applications in cancer treatment and inflammatory disorders. Santa Cruz Biotechnology monoclonal antibodies for VEGF-C support researchers worldwide in advancing our understanding of vascular biology and developing new therapeutic approaches.